(Q44001359)

28 November 2017

title

Interferon in viral hepatitis: role in pathogenesis and treatment (English)

1 reference

28 November 2017

1 reference

Davis GL

1

1 reference

28 November 2017

Hoofnagle JH

series ordinal

2

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 September 1986

1 reference

28 November 2017

1 reference

28 November 2017

volume

6

1 reference

28 November 2017

issue

5

1 reference

28 November 2017

page(s)

1038-1041

1 reference

UCLA conference. Interferon: immunobiology and clinical significance

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060537

Effects of recombinant human leukocyte interferon treatment of endogenous interferon production in patients with chronic type-B hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060537

Decreased Interferon Response by Lymphocytes from Children with Chronic Hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060537

Preliminary trial of recombinant fibroblast interferon in chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060537

Antiviral Treatment of Chronic Hepatitis B Virus Infection. I. Changes in Viral Markers with Interferon Combined with Adenine Arabinoside

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060537

Seroconversion from Hepatitis B e Antigen to Antibody in Chronic Type B Hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060537

Acute Dane particle suppression with recombinant leukocyte A interferon in chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060537

Antiviral treatment of chronic hepatitis B virus infection: pharmacokinetics and side effects of interferon and adenine arabinoside alone and in combination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060537

Determination of human leukocyte populations involved in production of interferons alpha and gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060537

7 January 2021

Studies of the interferon receptors

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060537

7 January 2021

Enhanced expression of β 2 -microglobulin and HLA antigens on human lymphoid cells by interferon

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060537

7 January 2021

Inhibition of human T lymphocyte function with monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060537

7 January 2021

Cutaneous interferon production in patients with Hodgkin's disease and other cancers infected with varicella or vaccinia.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060537

7 January 2021

Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. II. Studies with herpes simplex, Moloney sarcoma, vesicular stomatitis, Newcastle disease, and influenza viruses

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060537

7 January 2021

Absence of circulating interferon in patients with infectious and serum hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060537

7 January 2021

Failure to Demonstrate Circulating Interferon During Incubation Period and Acute Stage of Transfusion-Associated Hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060537

7 January 2021

Absence of detectable serum interferon in acute and chronic viral hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060537

7 January 2021

Interferon system in acute viral hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060537

7 January 2021

Acute type A hepatitis during chronic hepatitis B virus infection: association of depressed hepatitis B virus replication with appearance of endogenous alpha interferon

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060537

7 January 2021

Circulating interferon in patients with acute hepatitis A

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060537

7 January 2021

HLA class I antigens on the hepatocyte membrane during recovery from acute hepatitis B virus infection and during interferon therapy in chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060537

7 January 2021

Expression of beta 2-microglobulin on hepatocytes in acute and chronic type B hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060537

7 January 2021

Lack of in vivo activation of the interferon system in HBsAg-positive chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060537

7 January 2021

Assay of an interferon-induced enzyme in white blood cells as a diagnostic aid in viral diseases

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060537

7 January 2021

Hepatitis B virus and HLA antigen display in the liver during chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060537

7 January 2021

Lack of correlation between interferon production of mononuclear cells and virus replication in chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060537

7 January 2021

Interferon production by peripheral lymphocytes in HBsAg-positive liver diseases

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060537

7 January 2021

Production of interferon alpha and interferon gamma by peripheral blood leukocytes from patients with chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060537

7 January 2021

Fibroblast interferon in HBsAg-positive chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060537

7 January 2021

Treatment of HBsAg-positive chronic active hepatitis with human fibroblast interferon

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060537

7 January 2021

Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060537

7 January 2021

Double-blind study of leucocyte interferon administration in chronic HBsAg-positive hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060537

7 January 2021

Construction and identification of bacterial plasmids containing nucleotide sequence for human leukocyte interferon

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060537

7 January 2021

Pilot study of recombinant human alpha-interferon for chronic type B hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060537

7 January 2021

Recombinant leukocyte a interferon treatment in patients with chronic hepatitis B virus infection. Pharmacokinetics, tolerance, and biologic effects

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060537

7 January 2021

Changes of hepatitis B virus DNA in liver and serum caused by recombinant leukocyte interferon treatment: analysis of intrahepatic replicative hepatitis B virus DNA.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060537

7 January 2021

A randomized study of the effects of adenine arabinoside 5'-monophosphate (short or long courses) and lymphoblastoid interferon on hepatitis B virus replication.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060537

7 January 2021

Acyclovir enhances the antiviral effect of interferon in chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060537

7 January 2021

Identifiers

DOI

10.1002/HEP.1840060537

1 reference

28 November 2017

1 reference